Department of Anesthesiology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
J Anesth. 2015 Feb;29(1):102-11. doi: 10.1007/s00540-014-1857-z. Epub 2014 Jun 10.
Cardiac surgery is associated with a high incidence of cardiovascular and other complications during the perioperative period that translate into increased mortality and prolonged hospital stays. Safe comprehensive perioperative management is required to eliminate these adverse events. Dexmedetomidine is a selective α2-adrenoreceptor agonist that has been described as an ideal medication in the perioperative period of cardiac surgery. The major clinical effects of dexmedetomidine in this perioperative period can be summarized as attenuating the hemodynamic response, cardioprotective effects, antiarrhythmic effects, sedation in the ICU setting, treatment of delirium, and procedural sedation. Although there are some side effects of dexmedetomidine, it is emerging as an effective therapeutic agent in the management of a wide range of clinical conditions with an efficacious, safe profile. The present review serves as an overview update in the diverse applications of dexmedetomidine for cardiac surgery during the perioperative period.
心脏手术在围手术期会发生较高的心血管和其他并发症,导致死亡率增加和住院时间延长。需要安全全面的围手术期管理来消除这些不良事件。右美托咪定是一种选择性 α2-肾上腺素受体激动剂,已被描述为心脏手术围手术期的理想药物。右美托咪定在该围手术期的主要临床作用可概括为减轻血流动力学反应、心脏保护作用、抗心律失常作用、ICU 镇静、治疗谵妄和程序镇静。尽管右美托咪定有一些副作用,但它作为一种有效的治疗药物,在管理广泛的临床疾病方面具有有效的、安全的特性。本综述概述了右美托咪定在心脏手术围手术期的多种应用。